Company / Revenue per Share
Zymeworks Inc. Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.54
FY2025
5-year range
$0.51 / $1.54
FY2021-FY2025
Trend
+41.2%
vs FY2024
Sector context
#98 of 154
Health Care
What the data says
At $1.54, Zymeworks Inc.'s revenue per share ranks #98 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 6 years, ranging from $0.51 in FY2021 to $1.54 in FY2025.
Based on SEC 10-K filings.
1.54 in FY2025 with a 5-year CAGR of +14.7%.
Improved from $1.21 to $1.54 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +22.5%
- 5-Year CAGR
- +14.7%
- 10-Year CAGR
- -
Sector benchmark
#98 of 154 in Health CareTop 64% of 154This company $1.54 Sector average $15.09
▼
-89.8% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 41.2% year-over-year.
- Ranks #98 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.54 | +41.2% |
| FY2024 | $1.09 | -9.7% |
| FY2023 | $1.21 | +44.3% |
| FY2022 | $0.84 | +63.2% |
| FY2021 | $0.51 | -33.8% |
| FY2020 | $0.77 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026